Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Msi1 Overexpression in Diffuse Type of Gastric Cancer Publisher Pubmed



Nikpour P1, 2 ; Emadibaygi M3, 4 ; Mohhamadhashem F2 ; Maracy MR5 ; Haghjooyjavanmard S6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Inherited Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Division of Genetics, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Genetics, Faculty of Basic Sciences, Shahrekord University, Shahrekord, Iran
  4. 4. Research Institute of Biotechnology, Shahrekord University, Shahrekord, Iran
  5. 5. Department of Community Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Applied Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Pathology Research and Practice Published:2013


Abstract

Being the third most frequent cause of cancer mortality in the world, gastric cancer is the major cause of cancer-related mortality in Iran. Musashi1 recognizes a motif in the 3'UTR of target mRNAs - involved in cell cycle regulation, proliferation and apoptosis - and represses the translation of the mRNAs. As tissue stem cells exist in many adult tissues other than the CNS, Musashi is considered to be associated with many malignancies. In the current study, we aimed to assess Musashi1 gene expression in human stomach cancer. In total, 30 paired gastric tumoral and adjacent non-tumoral tissue specimens were examined for gene expression by qReal-Time RT-PCR. Our results demonstrated that the expression of the gene did not significantly change between tumor/non-tumor tissues (p value: 16×10-2) and different grades (p value: 36×10-2). However, there was a statistical difference between the MSI1 gene expression in different tumor types, i.e., intestinal versus diffuse type (p value: 3×10-2). All together, further investigations should be done to elucidate the precise molecular mechanisms by which MSI1 contribute to the pathogenesis of gastric cancer. © 2012 Elsevier GmbH.
Other Related Docs
20. Exploring Conserved Mrna-Mirna Interactions in Colon and Lung Cancers, Gastroenterology and Hepatology from Bed to Bench (2017)
27. Mir-146A Is Deregulated in Gastric Cancer, Journal of Cancer Research and Therapeutics (2019)
30. Long Non-Coding Rnas As Potential Biomarkers or Therapeutic Targets in Gastric Cancer, Gastroenterology and Hepatology from Bed to Bench (2023)
35. Network Analysis of Common Genes Related to Esophageal, Gastric, and Colon Cancers, Gastroenterology and Hepatology from Bed to Bench (2017)
39. Novel Somatic Variants in Ctnna1 Gene in Iranian Patients With Diffuse Gastric Cancer, Gastroenterology and Hepatology from Bed to Bench (2021)
44. Emerging Circulating Mirnas and Lncrnas in Upper Gastrointestinal Cancers, Expert Review of Molecular Diagnostics (2020)